US cosmetic registration is not a one-time task

A facility that manufactures or processes cosmetics marketed in the United States registers with the Food and Drug Administration and renews that registration every two years. The responsible person lists marketed products with their ingredients and updates the listing annually. FDA guidance requires the facility registration number in a product listing, so a product listing cannot stand on its own before the facility record.

Do not combine these three lines into one “renewal date.” A product listing’s annual update may arrive before the next facility renewal, and a changed facility-related record has its own 60-day deadline apart from regular renewal.

Facility registration and product listing are connected, but they are not the same record. A facility record concerns where cosmetics are manufactured or processed. A product listing concerns what is marketed and its ingredients.

Completion of one does not establish that the other is current.

An operating sheet therefore needs at least two rows. The facility row should hold the registration number, most recent registration date, next renewal date, and whether information changed. The product row should hold each product’s listing status, ingredient-check date, and next annual update.

One field called “FDA registration” cannot reveal whether a product addition or a facility change is still open.

No. FDA guidance says that a change to registration information must be reflected within 60 days. When facility information changes, the team should manage a separate deadline from the change date rather than wait for the next two-year renewal.

The first task is to establish what changed. Separate a change to facility-related registration information from a change to the marketed product or ingredient listing, or determine whether both changed. That distinction identifies the owner and the deadline.

Recording the changed fact, the source checked, and whether the update is complete in one row keeps the next operator from having to infer it.

A renewal task is not complete because one person “handles FDA.” The person who verifies facility-registration evidence, the person who checks each product’s ingredient listing, the person who reports a change, and the person who closes the submission should be distinguished so a deadline does not become ownerless.

Manufacturing, quality, international sales, and operations may hold different parts of the record. In the calendar, name one person who can check the source and evidence and decide whether that deadline is complete, rather than naming only a department.

A facility-related change can arise when no new product is launching. Do not make the facility row a child of the product-launch plan: a schedule that follows launches alone can miss a change to address, manufacturing, or processing information.

Product listing concerns marketed products and ingredients, so discontinued products and ingredient changes need their own check. Leaving a discontinued product on the list or treating a facility record as current without reflecting a changed ingredient can leave the record out of step with current sales.

Before a regular renewal, compare the calendar with current operating facts rather than checking a date alone. Because FDA guidance treats facility registration and product listing separately, compare current facility information and the current list of marketed products and ingredients separately too.

First, look at the facility row for information that changed after the most recent registration. A changed fact is not something to wait on until the next regular renewal; it calls for a check against the change date and the 60-day deadline.

Then review the product listing against products being marketed. Separating products that are no longer marketed, products missing from the list, and products whose ingredients need confirmation makes the concrete checks visible instead of calling everything “renewal.”

Finally, verify where the evidence lives. The useful test is whether the next operator can reopen the same record, not merely whether someone recalls submitting it, so do not close an item using only a personal inbox or a verbal confirmation.

This reconciliation does not decide registration eligibility by assumption. It checks whether records for facilities and products already being managed match current operations.

A renewal calendar should not just collect reminders. It should establish who must verify which fact. The following five fields let a team read facility registration and product listing in one table without treating either as a substitute for the other.

A “complete” label alone loses the basis for calculating the next action. Separating the reference date and next deadline makes it possible to distinguish an immediate task from a scheduled recheck.

Keep it visible on the same calendar, but do not combine it with a TikTok Shop onboarding review as if they were one step. FDA facility registration and product listing are Food and Drug Administration processes; Shop account and product review are platform processes. Completion of one must not close the other.

When building a launch schedule, do not only count backward from a release date. Also review the next annual update for products already marketed and whether facility information changed. New-product preparation and renewal for an existing product may have different owners, and a delay in either can change the operating decision for US sales.

This guide explains the operating cadence for FDA registration and listing. Whether a facility or product must be registered or listed, whether a small-business exemption applies, and which submission a particular change requires can vary with the product and business structure. Reopen the FDA source and seek the appropriate professional review before submitting.

Why is a launch-only review too late? FDA records are not only a document pack for the days before launch. A facility’s two-year cycle, a product listing’s annual update, and the 60-day deadline for a change arrive at different times, so a schedule focused only on launches can miss a deadline for a product already being marketed.

When preparing a new product, review the facility row’s most recent confirmation and next renewal date as well as the listing the product will join. An old record or an unclear change status can create a separate check alongside launch preparation.

Products already being marketed can disappear from a launch team’s task list. An annual update can arrive in a month with no new product, so product status needs to remain visible in an ongoing operating record rather than only a launch project.

Put an internal verification date before an external submission deadline. If there is no time to reopen the source and reconcile ingredients, facility information, and evidence location, finding omissions and submitting the update collide on the same day.

This does not promise an earlier deadline. It makes missing information visible first and preserves an order for checks before submission.